Comparison of the biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: Implications for the prediction of symptomatic and asymptomatic structural heart disease

被引：73

作者：

Mueller, T

Gegenhuber, A

Poelz, W

Haltmayer, M ^{[1
]}

机构：

[1] Konventhosp Barnherzige Brueder Linz, Dept Lab Med, A-4021 Linz, Austria

[2] Konventhosp Barnherzige Brueder Linz, Dept Internal Med, Div Cardiol, A-4021 Linz, Austria

[3] Univ Linz, Dept Appl Syst Sci & Stat, A-4040 Linz, Austria

来源：

CLINICAL CHEMISTRY | 2003年 / 49卷 / 06期

关键词：

D O I：

10.1373/49.6.976

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：976 / 979

页数：4

共 12 条

[1] Measuring agreement in method comparison studies [J].

Bland, JM ;

Altman, DG .

STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (02) :135-160

[2]

Clerico A, 2000, CLIN CHEM, V46, P1529

[3] Circulating N-terminal brain natriuretic peptide precursor and endothelin levels in patients with syndrome X and left bundle branch block with preserved systolic function [J].

Dudek, D ;

Rzeszutko, L ;

Dimitrow, PP ;

Bartus, S ;

Sorysz, D ;

Chyrchel, M ;

Rakowski, T ;

Zdzienicka, A ;

Guevara, I ;

Dembinska-Kiec, A ;

Dubiel, JS .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2001, 79 (01) :25-30

[4]

Hammerer-Lercher A, 2001, Clin Lab, V47, P265

[5] Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction [J].

Hammerer-Lercher, A ;

Neubauer, E ;

Müller, S ;

Pachinger, O ;

Puschendorf, B ;

Mair, J .

CLINICA CHIMICA ACTA, 2001, 310 (02) :193-197

[6] A METHOD OF COMPARING THE AREAS UNDER RECEIVER OPERATING CHARACTERISTIC CURVES DERIVED FROM THE SAME CASES [J].

HANLEY, JA ;

MCNEIL, BJ .

RADIOLOGY, 1983, 148 (03) :839-843

[7] ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the evaluation and management of heart failure) [J].

Hunt, SA ;

Baker, DW ;

Chin, MH ;

Cinquegrani, MP ;

Feldman, AM ;

Francis, GS ;

Ganiats, TG ;

Goldstein, S ;

Gregoratos, G ;

Jessup, ML ;

Noble, RJ ;

Packer, M ;

Silver, MA ;

Stevenson, LW ;

Gibbons, RJ ;

Antman, EM ;

Alpert, JS ;

Faxon, DP ;

Fuster, V ;

Gregoratos, G ;

Jacobs, AK ;

Hiratzka, LF ;

Russell, RO ;

Smith, SC .

CIRCULATION, 2001, 104 (24) :2996-3007

[8]

Karl J, 1999, SCAND J CLIN LAB INV, V59, P177

[9]

Mair J, 2002, CLIN CHEM, V48, P977

[10]

MISSBICHLER A, 1999, J LAB MED, V23, P241

← 1 2 →